New asthma inhaler shows promise in early trial
NCT ID NCT07324707
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new asthma inhaler called PA9159 in 30 adults with asthma. The goal is to see if it improves lung function and is safe over 4 weeks. Participants will use the inhaler and have their breathing measured regularly.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRONCHIAL ASTHMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The First Affiliated Hospital of Nanchang University
RECRUITINGNanchang, Jiangxi, 330006, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a chromium supplement help obese adults breathe easier?
- Can acupuncture stop an asthma attack? new study investigates
- Golfers test N95 masks to breathe easy in wildfire smoke
- Massive study reveals hidden dangers of common steroid treatments
- Breath prints may reveal lung disease secrets without needles
- Asthma drug roflumilast tested for Long-Term safety in new study